|

Cisplatin or Carboplatin Clinical Trials

4 actively recruiting trials

▲ +1 trial since August 2026

Also known as: Cisplatin, carboplatin

Pipeline

Phase 1: 1Phase 2: 2Phase 3: 1

Top Sponsors

  • Shanghai Junshi Bioscience Co., Ltd.1
  • Shanghai JMT-Bio Inc.1
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1
  • Fudan University1

Indications

  • Cancer4
  • Lung Cancer2
  • Brain Metastasases1
  • Head Neck Cancer1
  • TNBC - Triple-Negative Breast Cancer1

Other4 trials

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Phase 1
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs
Phase 3
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 2
Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.